Recent Update on the Development of Leucine-Rich Repeat Kinase 2(LRRK2) Inhibitors: A Promising Target for the Treatment of Parkinson’sDiseaseAshish Patel, Tushar Bambharoliya, Shyam Bhalodiya et al.|Medicinal Chemistry|2022Cited by 4